Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Assessing Developability And Designing Advanceable Formulations From The Start
Discover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.
-
Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development
Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.
-
Improving Swallowing And Palatability With Patient‑Friendly Forms
Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.
-
Fast-Tracking FIH To PoC: Strategies For Accelerated Drug Development
Three factors often decide success or failure in FIH studies: integrating biomarkers and pharmacodynamic endpoints, including patients in the trials, and leveraging purpose-built manufacturing infrastructure.
-
Matrix Approach Enhances Potency Assay Development For ATMPs
Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
MicroCoat™ Technology DFor Taste-Masking Amodiaquine, Artesunate In Oral Antimalarial Formulations
Drive forward the development and adoption of taste‑masked ASAQ micropellets so children in low‑resource settings can receive life‑saving antimalarial treatment that is both effective and easy to take.
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
-
Remote Measurements For Bulk Samples
Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.
-
Lentiviral Vector Upstream Process
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
FORMULATION DEVELOPMENT SOLUTIONS
- R&D And Analytical Services
- Our Science-Forward Approach To API Development, Manufacturing
- A Quick Guide To Dissolution Testing
- Continuous Flow
- ADC And Bioconjugation Center Of Excellence
- Eliminate Doubt With Chemistry Technical Services
- Oligonucleotide Discovery And Development
- Control Your Bioprocess Development: Faster Decisions With Quality Data
- Automated Cell Imaging System
- MaxPeak Premier Columns For Protein SEC Analysis
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Veranova Appoints Jacquelyn Martin As Chief Quality Officer
- Halo Pharma To Become A Stand-Alone Drug Product Contract Development And Manufacturing Organization (CDMO)
- Eurofins CDMO Alphora Announces Development & Implementation Of AI-Powered Salt And Co-Crystal Screening Software
- Coating Place Announces Leadership Appointments To Support Next Phase Of Growth
- Mikart Celebrates 50 Years Of Excellence In Pharmaceutical Manufacturing
- Mikart Signs Lease For New Headquarters At Cumberland Center II In Northwest Atlanta
- Genentech To Double Its Investment At North Carolina Drug Manufacturing Facility
- CDMO Alcami Expands RTP Footprint With New Durham Facility And Major Lab Expansion
- Wilmington PharmaTech Appoints Seasoned Commercial Leader To Drive Growth
- Coating Place Secures Growth Capital Investment By 1315 Capital